Brian Lauritzen

754 total citations
37 papers, 588 citations indexed

About

Brian Lauritzen is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Brian Lauritzen has authored 37 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 6 papers in Surgery and 6 papers in Genetics. Recurrent topics in Brian Lauritzen's work include Hemophilia Treatment and Research (19 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Hemostasis and retained surgical items (7 papers). Brian Lauritzen is often cited by papers focused on Hemophilia Treatment and Research (19 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Hemostasis and retained surgical items (7 papers). Brian Lauritzen collaborates with scholars based in Denmark, United States and United Kingdom. Brian Lauritzen's co-authors include Jens Lykkesfeldt, Mirella Ezban, Mikael Tranholm, Christian Friis, Ove Svendsen, Ida Hilden, Øystein Angen, Jens Peter Nielsen, Pär I. Johansson and Jens Breinholt and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Anaesthesia.

In The Last Decade

Brian Lauritzen

36 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Lauritzen Denmark 14 300 87 76 65 62 37 588
Sharron L. O’Neill United States 11 106 0.4× 16 0.2× 28 0.4× 36 0.6× 26 0.4× 20 338
Yong Wu China 18 52 0.2× 13 0.1× 48 0.6× 117 1.8× 208 3.4× 39 912
Jeffress G. Palmer United States 12 57 0.2× 45 0.5× 24 0.3× 49 0.8× 68 1.1× 22 478
Neil C. Olson United States 15 29 0.1× 9 0.1× 27 0.4× 88 1.4× 106 1.7× 53 675
Levine As United States 10 62 0.2× 21 0.2× 7 0.1× 36 0.6× 108 1.7× 19 605
Barbara J. Berger United States 9 22 0.1× 16 0.2× 28 0.4× 77 1.2× 78 1.3× 16 507
Earl W. Ferguson United States 15 80 0.3× 8 0.1× 21 0.3× 43 0.7× 69 1.1× 27 612
William W. Brinkley United States 9 35 0.1× 20 0.2× 49 0.6× 43 0.7× 122 2.0× 16 511
A. Emin Kürekçi Türkiye 13 88 0.3× 206 2.4× 6 0.1× 151 2.3× 150 2.4× 30 694
DD Poutsiaka United States 7 60 0.2× 4 0.0× 24 0.3× 69 1.1× 124 2.0× 10 623

Countries citing papers authored by Brian Lauritzen

Since Specialization
Citations

This map shows the geographic impact of Brian Lauritzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Lauritzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Lauritzen more than expected).

Fields of papers citing papers by Brian Lauritzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Lauritzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Lauritzen. The network helps show where Brian Lauritzen may publish in the future.

Co-authorship network of co-authors of Brian Lauritzen

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Lauritzen. A scholar is included among the top collaborators of Brian Lauritzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Lauritzen. Brian Lauritzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lauritzen, Brian, Olle Björkdahl, Esther Bloem, et al.. (2022). A novel next‐generation FVIIIa mimetic, Mim8, has a favorable safety profile and displays potent pharmacodynamic effects: Results from safety studies in cynomolgus monkeys. Journal of Thrombosis and Haemostasis. 20(6). 1312–1324. 27 indexed citations
2.
Elm, Torben, et al.. (2021). Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice. Journal of Visualized Experiments. 3 indexed citations
3.
Bolt, Michael W., Laurence O. Whiteley, Jessica Lynch, et al.. (2020). Nonclinical Studies that Support Viral Vector-Delivered Gene Therapies: An EFPIA Gene Therapy Working Group Perspective. Molecular Therapy — Methods & Clinical Development. 19. 89–98. 5 indexed citations
4.
Andersson, Christina, Peter Helding Kvist, Kathryn McElhinney, et al.. (2015). Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis. PLoS ONE. 10(6). e0128113–e0128113. 14 indexed citations
5.
Lykkesfeldt, Jens, et al.. (2012). A sensitive venous bleeding model in haemophilia A mice: effects of two recombinant FVIII products (N8 and Advate®). Haemophilia. 18(5). 782–788. 38 indexed citations
6.
Grottke, Oliver, Till Braunschweig, R. Kopp, et al.. (2010). Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs. British Journal of Anaesthesia. 105(6). 789–797. 7 indexed citations
7.
Lauritzen, Brian, Dorthe Viuff, Mikael Tranholm, & Mirella Ezban. (2010). rFVIIa and NN1731 Reduce Bleeding in Hydroxyethyl Starch Hemodiluted Rabbits. The Journal of Trauma: Injury, Infection, and Critical Care. 69(5). 1196–1202. 3 indexed citations
8.
Lauritzen, Brian, et al.. (2009). Faster onset of effect and greater efficacy of NN1731 compared with rFVIIa, aPCC and FVIII in tail bleeding in hemophilic mice. Journal of Thrombosis and Haemostasis. 7(9). 1517–1522. 33 indexed citations
9.
Lauritzen, Brian, Mikael Tranholm, & Mirella Ezban. (2009). rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats. Journal of Thrombosis and Haemostasis. 7(4). 651–657. 21 indexed citations
10.
Lauritzen, Brian, Ulla Hedner, Peter Johansen, Mikael Tranholm, & Mirella Ezban. (2008). Recombinant human factor VIIa and a factor VIIa‐analogue reduces heparin and low molecular weight heparin (LMWH)‐induced bleeding in rats. Journal of Thrombosis and Haemostasis. 6(5). 804–811. 23 indexed citations
11.
McMullin, Neil R., Ulla Hedner, Mirella Ezban, et al.. (2008). RECOMBINANT FACTOR VIIA REDUCES REBLEED HEMORRHAGE VOLUME IN A SWINE AORTOTOMY MODEL. Shock. 29(6). 703–708. 3 indexed citations
12.
Viuff, Dorthe, et al.. (2008). Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven®). British Journal of Anaesthesia. 101(3). 324–331. 21 indexed citations
13.
Henriksen, Lars Onsberg, et al.. (2008). Automated registration of tail bleeding in rats. Thrombosis and Haemostasis. 99(11). 956–962. 5 indexed citations
14.
Lykkegaard, Kirsten, Jens Lykkesfeldt, Brian Lauritzen, & Ole Lander Svendsen. (2007). Morphine reduces spinal c-fos expression dose-dependently during experimental laparotomy in pigs: A combined pharmacokinetic and surgical study. Research in Veterinary Science. 84(3). 457–464. 5 indexed citations
15.
Svendsen, Ove, et al.. (2006). Spinal Nociception Induced by Intramuscular Injection of Oxytetracycline Preparations in Rats and Pigs. Basic & Clinical Pharmacology & Toxicology. 99(1). 58–61. 3 indexed citations
16.
Svendsen, Ove, et al.. (2005). Intramuscular Injection of Hypertonic Saline: In vitro and in vivo Muscle Tissue Toxicity and Spinal Neurone c‐fos Expression. Basic & Clinical Pharmacology & Toxicology. 97(1). 52–57. 20 indexed citations
17.
Lykkegaard, Kirsten, et al.. (2005). Local anaesthetics attenuates spinal nociception and HPA-axis activation during experimental laparotomy in pigs. Research in Veterinary Science. 79(3). 245–251. 23 indexed citations
18.
Lauritzen, Brian, Jens Lykkesfeldt, & Christian Friis. (2004). Evaluation of a single dose versus a divided dose regimen of amoxycillin in treatment of Actinobacillus pleuropneumoniae infection in pigs. Research in Veterinary Science. 79(1). 61–67. 13 indexed citations
19.
Lauritzen, Brian, Jens Lykkesfeldt, & Christian Friis. (2003). Evaluation of a single dose versus a divided dose regimen of danofloxacin in treatment of Actinobacillus pleuropneumoniae infection in pigs. Research in Veterinary Science. 74(3). 271–277. 33 indexed citations
20.
Lauritzen, Brian, et al.. (2003). Putative biomarkers for evaluating antibiotic treatment: an experimental model of porcine Actinobacillus pleuropneumoniae infection. Research in Veterinary Science. 74(3). 261–270. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharron L. O’Neill Breakdown of academic impact, for papers by Yong Wu Breakdown of academic impact, for papers by Jeffress G. Palmer Breakdown of academic impact, for papers by Neil C. Olson Breakdown of academic impact, for papers by Levine As Breakdown of academic impact, for papers by Barbara J. Berger Breakdown of academic impact, for papers by Earl W. Ferguson Breakdown of academic impact, for papers by William W. Brinkley Breakdown of academic impact, for papers by A. Emin Kürekçi Breakdown of academic impact, for papers by DD Poutsiaka
Rankless by CCL
2026